Khabnadideh Soghra, Solhjoo Aida, Heidari Reza, Amiri Zirtol Leila, Sakhteman Amirhossein, Rezaei Zahra, Babaei Elaheh, Rahimi Samaneh, Emami Leila
Pharmaceutical Sciences Research Center, Shiraz University of Medical Sciences, Shiraz, Iran.
Department of Medicinal Chemistry, Faculty of Pharmacy, Shiraz University of Medical Sciences, Shiraz, Iran.
BMC Chem. 2022 Jun 10;16(1):44. doi: 10.1186/s13065-022-00836-8.
A series of 2-aryl/alkyl-2,3-dihydro-1H-naphtho[1,2-e][1,3]oxazines (S-S) were synthesized with an eco-friendly and recoverable nanocatalyst (GO-FeO-Ti) as an efficient magnetic composite. The new nanocatalyst was characterized by FT-IR, XRD and, EDS analysis. A conformable procedure, easy to work up and having a short reaction time with high yields are some advantages of this method. The new catalyst is also thermal-stable, reusable and, environment-friendly. The chemical structures of the synthesized 1,3-oxazine compounds were confirmed by comparing their melting points with those reported in literature. Then, the anticonvulsant activity of these compounds was assessed by the intraperitoneal pentylenetetrazole test (ipPTZ). Compounds S and S displayed considerable activity against chemically-induced seizure tests. The molecular simulation was also done to achieve their binding affinities as γ-aminobutyric acid A (GABA-A) receptor agonists as an assumptive mechanism of their anticonvulsant action. The result of molecular studies represented strongly matched with biological activity. Molecular docking simulation of the potent compound (S) and diazepam as the positive control was performed and some critical residues like Thr262, Asn265, Met286, Phe289, and Val290 were identified. Based on the anticonvulsant results and also in silico ADME predictions, S can be to become a potential drug candidate as an anticonvulsant agent.
以一种环保且可回收的纳米催化剂(GO-FeO-Ti)作为高效磁性复合材料,合成了一系列2-芳基/烷基-2,3-二氢-1H-萘并[1,2-e][1,3]恶嗪(S-S)。通过傅里叶变换红外光谱(FT-IR)、X射线衍射(XRD)和能谱分析(EDS)对这种新型纳米催化剂进行了表征。该方法具有操作简便、后处理容易、反应时间短且产率高的优点。这种新型催化剂还具有热稳定性、可重复使用性且环境友好。通过将合成的1,3-恶嗪化合物的熔点与文献报道的熔点进行比较,确认了其化学结构。然后,通过腹腔注射戊四氮试验(ipPTZ)评估了这些化合物的抗惊厥活性。化合物S和S在化学诱导惊厥试验中表现出相当的活性。还进行了分子模拟,以确定它们作为γ-氨基丁酸A(GABA-A)受体激动剂的结合亲和力,作为其抗惊厥作用的一种假定机制。分子研究结果与生物活性高度匹配。对强效化合物(S)和作为阳性对照的地西泮进行了分子对接模拟,并确定了一些关键残基,如苏氨酸262、天冬酰胺265、甲硫氨酸286、苯丙氨酸289和缬氨酸290。基于抗惊厥结果以及计算机辅助药物代谢动力学(ADME)预测,S有望成为一种潜在的抗惊厥药物候选物。